KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.

Today, we are talking about using cognitive behavioral therapy to treat Obsessive-Compulsive Disorder in clinical settings. 

A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.

Should we follow the FDA and give SSRIs, or venture off-label with the fabled prazosin?

Learn what therapies work for PTSD, what goes on in session, and how to prevent PTSD when your patient calls after a trauma.

The transition to college can be challenging for any adolescent, but when an adolescent has psychological conditions, or they're dealing with other mental health concerns, it is especially difficult to navigate this transition.

Why do some people get PTSD after a trauma and not others? What goes on in the brain during PTSD.

Why do some people get PTSD after a trauma and not others? What goes on in the brain during PTSD.

Today, we are talking about dysmorphology and genetic disorders in psychiatry. Dr. Marilyn Jones joins us to help us identify and understand these conditions. Dr. Jones tells us about the prevalence and diagnostic considerations for these conditions, such as 22q and Fragile X. Join us as we talk about the importance of early identification, genetic testing, and strategies for supporting individuals and families affected by these conditions.

Research updates on benzo discontinuation, iloperidone in mania, lithium, schizophrenia, ECT, a new circadian psychotherapy, and therapy for multi-trauma PTSD.